Table 4 Diagnostic performance of cytology and BRAFV600E genetic testing in FNAB + BRAF group.

From: BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration

 

Cytology

positive

BRAFV600E

positive

Either Cytology or BRAFV600E positive

Both Cytology and BRAFV600E positive

Sensitivity

95.23%

90.30%

98.98%

86.54%

Specificity

83.33%

94.44%

80.56%

97.22%

Positive predictive value

99.68%

99.89%

99.64%

99.94%

Negative predictive value

24.19%

15.11%

59.18%

11.67%

Accuracy

95.01%

90.37%

98.65%

86.73%